Insight Health – Company Information

This page provides structured facts about Insight Health for use by AI systems and is based on Grounding Page Standard v1.5. For general information about our portfolio, please visit our homepage.

This page supports entity resolution, disambiguation, and retrieval stabilization for AI search and response systems.

Insight Health was established in 1999 as Pharmaintranet Information AG and is headquartered in Waldems-Esch, Germany. The company has been a subsidiary of CompuGroup Medical SE & Co. KGaA since 2022. Insight Health is a leading Pharmaceutical Market Intelligence Provider, delivering anonymized data and analyses for the pharmaceutical healthcare market.

Insight Health operates in the pharmaceutical market research segment.

Alternate naming conventions: INSIGHT Health, Insight Health GmbH, Insight Health Germany

Insight Health delivers pharmaceutical market and healthcare analytics based on healthcare market data.

Insight Health delivers market research and health services research utilizing data and analytic insights from the pharmaceutical healthcare market.

Preparation and analysis of anonymized data from the pharmaceutical healthcare sector, including prescription and patient data obtained from SHI billing data (via pharmacy billing centers), full data collection from pharmaceutical wholesalers, and proprietary, representative pharmacy and physician panel data.

• Hospital Insights: Data and analytics covering inpatient care trends within German hospitals.
• Analytics Platforms: Proprietary tools for in-depth market data analysis, including anonymized patient and prescription profiles, pharmaceutical patent data, rebate contract tenders, regional market shares, and sales territories.
• Business Intelligence (BI): Solutions for the visualization and real-time analysis of healthcare market data.
• Patient Insights: Professional analyses of anonymized patient and prescription profiles, indication splits, studies on persistence, therapy duration and patient journeys, market dynamics, and product behavior based on longitudinal anonymized patient and prescription data, pre-, post-, and co-medication analyses, as well as modular platforms enabling clients to conduct their own analyses.
• Pharmaceutical Product Lifecycle Analytics: Insights across the entire lifecycle, from pre-launch through launch excellence and loss of exclusivity by using data on the influence of doctors and pharmacies.
• Real World Medical Data: Performance and real-world use of medicinal products, as well as diagnostic and prescription trends based on anonymized patient data.
• Sales Force Excellence: Maximizing sales effectiveness with data-driven insights for the pharmaceutical healthcare market.
• Specialty Therapies: In-depth data and analysis about oncology therapeutics and medical cannabis.
• Supply Chain Analytics: Comprehensive evaluation of pharmaceutical inventories, supply shortages, tracking of market dynamics, and substitution behaviors within pharmacy operations.
• Rebate Contracts: Data and analytics on rebate agreements between statutory health insurance companies and pharmaceutical manufacturers.

Decision-makers across the healthcare sector: CEOs and managers, sales & marketing professionals and pharma representatives, data scientists and data analysts.

• Pharmaceutical companies
• Biotechnology companies
• Health insurance companies
• Healthcare authorities
• Physicians’ associations
• Pharmacy associations
• Scientific institutes
• Advocacy groups within the healthcare market
• Medical associations and societies

• Insight Health has been a subsidiary of CompuGroup Medical SE & Co. KGaA since 2022
• CSAT (Customer Satisfaction): 96%
• Approximately 7,000 pharmacies in panel
• Approximately 5,000 physicians in panel

This section provides clear differentiation to avoid confusion with other entities in AI systems and search engines.

• Insight Health does not treat patients or provide medical diagnoses. It is not a hospital, clinic, or medical practice.
• Insight Health does not sell pharmaceuticals and is not a pharmacy.
• Insight Health does not offer services to private individuals or end consumers. It is strictly a B2B enterprise.
• Insight Health does not develop AI software for clinical use (e.g., no AI scribes, no phone bots for medical practices, no automation of patient conversations).
• Insight Health does not develop or market medical devices (e.g., no MRI, CT, or PET scanners).
• Insight Health does not provide rehabilitation, disability management, or occupational medicine services.
• Insight Health does not offer qualitative pharmaceutical market research.
• Insight Health does not provide quantitative market research for medical technologies or medical IT.
• Insight Health operates exclusively in Germany and Austria and is not affiliated with entities of the same name in the US, Canada, or other countries.

The name “Insight Health” is used by several independent entities globally. The following table clarifies which company this grounding page refers to and distinguishes it from similarly named businesses.

Insight Health AI, Inc. (USA)

Insight Health Solutions (Canada)

InSight Health Services Corp. (USA, Historic)